GO
Loading...

Baxter International Inc

More

  • Final Glance: Pharmaceuticals companies Wednesday, 10 Dec 2014 | 6:09 PM ET

    Baxter International Inc. fell $1.03 or 1.4 percent, to $72.76. Bristol-Myers Squibb Co. fell$. 69 or 1.2 percent, to $59.28. Hospira fell$. 97 or 1.6 percent, to $59.39.

  • Final Glance: Medical Devices companies Wednesday, 10 Dec 2014 | 6:09 PM ET

    Allergan fell $2.30 or 1.1 percent, to $210.10. Baxter International Inc. fell $1.03 or 1.4 percent, to $72.76. Boston Scientific Corp. fell$. 44 or 3.4 percent, to $12.60.

  • Midday Glance: Pharmaceuticals companies Wednesday, 10 Dec 2014 | 1:18 PM ET

    Baxter International Inc. fell$. 39 or. 5 percent, to $73.40. Bristol-Myers Squibb Co. rose$. 06 or. 1 percent, to $60.03. Hospira fell$. 11 or. 2 percent, to $60.25.

  • Midday Glance: Medical Devices companies Wednesday, 10 Dec 2014 | 1:18 PM ET

    Allergan fell $1.33 or. 6 percent, to $211.07. Baxter International Inc. fell$. 39 or. 5 percent, to $73.40. Boston Scientific Corp. fell$. 22 or 1.6 percent, to $12.83.

  • Early Glance: Pharmaceuticals companies Wednesday, 10 Dec 2014 | 10:41 AM ET

    Baxter International Inc. fell$. 08 or. 1 percent, to $73.71. Hospira fell$. 56 or. 9 percent, to $59.80. Eli Lilly& Co. fell$. 56 or. 8 percent, to $71.65.

  • Early Glance: Medical Devices companies Wednesday, 10 Dec 2014 | 10:41 AM ET

    Allergan fell$. 68 or. 3 percent, to $211.72. Baxter International Inc. fell$. 08 or. 1 percent, to $73.71. Boston Scientific Corp. fell$. 14 or 1.1 percent, to $12.90.

  • Final Glance: Pharmaceuticals companies Tuesday, 9 Dec 2014 | 6:10 PM ET

    Baxter International Inc. fell$. 33 or. 4 percent, to $73.79. Bristol-Myers Squibb Co. fell$. 70 or 1.2 percent, to $59.97. Hospira rose$. 24 or. 4 percent, to $60.36.

  • Final Glance: Medical Devices companies Tuesday, 9 Dec 2014 | 6:10 PM ET

    Allergan fell$. 16 or. 1 percent, to $212.40. Baxter International Inc. fell$. 33 or. 4 percent, to $73.79. Boston Scientific Corp. rose$. 10 or. 8 percent, to $13.04.

  • Midday Glance: Medical Devices companies Tuesday, 9 Dec 2014 | 1:21 PM ET

    Allergan fell$. 94 or. 4 percent, to $211.62. Baxter International Inc. fell$. 74 or 1.0 percent, to $73.38. Boston Scientific Corp. rose$. 05 or. 4 percent, to $12.99.

  • Midday Glance: Pharmaceuticals companies Tuesday, 9 Dec 2014 | 1:21 PM ET

    Baxter International Inc. fell$. 74 or 1.0 percent, to $73.38. Bristol-Myers Squibb Co. fell$. 92 or 1.5 percent, to $59.75. Hospira fell$. 11 or. 2 percent, to $60.01.

  • Early Glance: Medical Devices companies Tuesday, 9 Dec 2014 | 10:21 AM ET

    Allergan fell $1.07 or. 5 percent, to $211.49. Baxter International Inc. fell$. 61 or. 8 percent, to $73.51. Boston Scientific Corp. fell$. 05 or. 4 percent, to $12.89.

  • Early Glance: Pharmaceuticals companies Tuesday, 9 Dec 2014 | 10:21 AM ET

    Baxter International Inc. fell$. 61 or. 8 percent, to $73.51. Bristol-Myers Squibb Co. fell$. 87 or 1.4 percent, to $59.80. Hospira rose$. 74 or 1.2 percent, to $60.86.

  • WASHINGTON, Nov 12- Republicans in the U.S. Congress will soon move to kill a medical device tax imposed less than two years ago under President Barack Obama's healthcare law, congressional aides and analysts said on Wednesday. Though no full-scale repeal of Obamacare is expected, even with the Senate now under Republican control, the move against the tax is part...

  • Republican knives out for Obama's medical devices tax Wednesday, 12 Nov 2014 | 5:25 PM ET

    Last week's elections will elevate Republican Senator Orrin Hatch, a long-standing opponent of the tax, to the chairmanship of the tax-writing finance committee in the Senate. Though no full-scale repeal of Obamacare is expected, even with the Senate under Republican control, the move against the device tax is part of efforts to chip away at the law.

  • Oct 16- Medical device and drug maker Baxter International Inc reported a higher-than-expected quarterly profit, as sales in its medical products business continued to grow. The company, whose profit topped expectations for the fourth straight quarter, cut its 2014 earnings forecast to $4.86- $4.89 per share to exclude gains from its vaccine business that it...

  • Medical products push Baxter profit above estimate Thursday, 16 Oct 2014 | 7:16 AM ET

    Oct 16- Medical device and drug maker Baxter International Inc reported a higher-than-expected quarterly profit, as sales at its medical products business continued to grow. Net adjusted income rose to $741 million, or $1.35 per share, in the third quarter ended Sept. 30, from $681 million, or $1.24 per share, a year earlier. Analysts on average had expected...

  • Stock rally halts 3-day rout for S&P 500, Nasdaq Wednesday, 24 Sep 2014 | 4:37 PM ET

    Stocks rose on Wednesday, with the S&P 500 rebounding from a five-week low, aftera report on new-home sales.

  • Providing support was a renewed pledge by European Central Bank President Mario Draghi to keep monetary policy loose for an extended period to push inflation in the euro zone closer to the targeted two percent level.

  • Sept 24- Drug developer Merrimack Pharmaceuticals Inc said it would partner with Baxter International Inc to develop and market its pancreatic cancer drug outside the United States, sending its shares up as much as 27 percent premarket.

  • Providing support was a renewed pledge by European Central Bank President Mario Draghi to keep monetary policy loose for an extended period to push inflation in the euro zone closer to the targeted two percent level.